COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 698: Articles 6971-6980  | Next

Immunogenicity and safety of coadministration of COVID-19 and influenza vaccination among healthcare workers
Wagenhäuser, I., Reusch, J., Gabel, A., Höhn, A., Lam, T.-T., Almanzar, G., Prelog, M., Krone, L. B., Frey, A., Schubert-Unkmeir, A., Dölken, L., Frantz, S., Kurzai, O., Vogel, U., Petri, N., Krone, M.
10.1101/2022.06.09.22276030 — Posted: 2022-06-14
Effect of HIV disease and the associated moderators on COVID-19 related Mortality
MUTHUKA, J. K., Wambura, F., Oluoch, K., Mativo, J. N.
10.1101/2022.06.09.22275881 — Posted: 2022-06-14
Telemedicine Ready or Not? a cross-sectional assessment of telemedicine maturity of federally funded tertiary health institutions in Nigeria.
Olufunlayo, T. F., Ojo, O. O., Ozoh, O. B., Fasanmade, O. A., Agabi, O. P., Taiwo, F. T., Opara, C. R., Okubadejo, N. U.
10.1101/2022.06.13.22276341 — Posted: 2022-06-14
Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapy
Katz Sand, I., Gnjatic, S., Krammer, F., Tuballes, K., Carreno Quiroz, J. M., Satyanarayan, S., Filomena, S., Staker, E., Tcheou, J., Miller, A., Fabian, M., Safi, N., Nichols, J., Patel, J., Krieger, S., Tankou, S., Horng, S., Klineova, S., Beck, E., Merad, M., Lublin, F.
10.1101/2022.06.10.22276253 — Posted: 2022-06-14
Evaluation of anti-SARS-CoV-2 antibody response to COVID-19 vaccine deployment in the Bono Region, Ghana.
Gyasi, S. F., Timmy-Donkoh, E., Frempong, S., Asamoah, A., Raji, A. S., Baidoo, R. C., Isaac, W., Essel, D., Asakiya, H. A.
10.1101/2022.06.09.22276192 — Posted: 2022-06-14
Immunosuppression as a hub for SARS-CoV-2 mutational drift
Shapira, G., Patalon, T., Gazit, S., Shomron, N.
10.1101/2022.06.09.22276203 — Posted: 2022-06-14
HEALTHCARE UTILISATION IN PATIENTS WITH LONG-TERM CONDITIONS DURING THE COVID-19 PANDEMIC: A POPULATION BASED STUDY ACROSS GREATER MANCHESTER, UK
Sammut-Powell, C., Williams, R., Sperrin, M., Thomas, O., Peek, N., Grant, S. W.
10.1101/2022.06.09.22276232 — Posted: 2022-06-14
Stratifying elicited antibody dynamics after two doses of SARS-CoV-2 vaccine in a community-based cohort in Fukushima, Japan
Nakamura, N., Kobashi, Y., Kim, K. S., Tani, Y., Shimazu, Y., Zhao, T., Nishikawa, Y., Omata, F., Kawashima, M., Yoshida, M., Abe, T., Saito, Y., Senoo, Y., Nonaka, S., Takita, M., Yamamoto, C., Kawamura, T., Sugiyama, A., Nakayama, A., Kaneko, Y., Park, H., Jeong, Y. D., Tatematsu, D., Akao, M., Sato, Y., Iwanami, S., Fujita, Y., Wakui, M., Aihara, K., Kodama, T., Shibuya, K., Iwami, S., Tsubokura, M.
10.1101/2022.06.11.22276266 — Posted: 2022-06-14
Assessing COVID-19 vaccination strategies in varied demographics using an individual-based model
Ben-Zuk, N., Daon, Y., Sasson, A., Ben-Adi, D., Huppert, A., Nevo, D., Obolski, U.
10.1101/2022.06.11.22276248 — Posted: 2022-06-14
The impact of Test Positivity on Surveillance with Asymptomatic Carriers
Gaspari, M.
10.1101/2022.06.10.22276234 — Posted: 2022-06-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).